Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor

Obesity, altered glucose homeostasis, hyperinsulinism, and reproductive dysfunction develops in female humans and mammals with hyperandrogenism. We previously reported that low dose dihydrotestosterone (DHT) administration results in metabolic and reproductive dysfunction in the absence of obesity i...

Full description

Bibliographic Details
Main Authors: Mingxiao Feng, Sara Divall, Dustin Jones, Vaibhave Ubba, Xiaomin Fu, Ling Yang, Hong Wang, Xiaofeng Yang, Sheng Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.868572/full
_version_ 1818161383714324480
author Mingxiao Feng
Sara Divall
Dustin Jones
Vaibhave Ubba
Xiaomin Fu
Xiaomin Fu
Ling Yang
Hong Wang
Xiaofeng Yang
Sheng Wu
Sheng Wu
author_facet Mingxiao Feng
Sara Divall
Dustin Jones
Vaibhave Ubba
Xiaomin Fu
Xiaomin Fu
Ling Yang
Hong Wang
Xiaofeng Yang
Sheng Wu
Sheng Wu
author_sort Mingxiao Feng
collection DOAJ
description Obesity, altered glucose homeostasis, hyperinsulinism, and reproductive dysfunction develops in female humans and mammals with hyperandrogenism. We previously reported that low dose dihydrotestosterone (DHT) administration results in metabolic and reproductive dysfunction in the absence of obesity in female mice, and conditional knock-out of the androgen receptor (Ar) in the liver (LivARKO) protects female mice from DHT-induced glucose intolerance and hyperinsulinemia. Since altered metabolic function will regulate reproduction, and liver plays a pivotal role in the reversible regulation of reproductive function, we sought to determine the reproductive phenotype of LivARKO mice under normal and hyperandrogenemic conditions. Using Cre/Lox technology, we deleted the Ar in the liver, and we observed LivARKO female mice have normal puberty timing, cyclicity and reproductive function. After DHT treatment, like control mice, LivARKO experience altered estrous cycling, reduced numbers of corpus lutea, and infertility. Liver Ar is not involved in hyperandrogenemia-induced reproductive dysfunction. The reproductive dysfunction in the DHT-treated LivARKO lean females with normal glucose homeostasis indicates that androgen-induced reproductive dysfunction is independent from metabolic dysfunction.
first_indexed 2024-12-11T16:16:54Z
format Article
id doaj.art-433ff166b7e3428eb40c306fb79e81d7
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-11T16:16:54Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-433ff166b7e3428eb40c306fb79e81d72022-12-22T00:58:56ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.868572868572Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen ReceptorMingxiao Feng0Sara Divall1Dustin Jones2Vaibhave Ubba3Xiaomin Fu4Xiaomin Fu5Ling Yang6Hong Wang7Xiaofeng Yang8Sheng Wu9Sheng Wu10Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Pediatrics, Seattle’s Children’s Hospital, University of Washington, Seattle, WA, United StatesDepartment of Cellular and Molecular Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Cardiovascular Sciences/Center for Metabolic Disease Research, Temple University School of Medicine, Philadelphia, PA, United StatesDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, ChinaMedical Genetics and Molecular Biochemistry, Temple University School of Medicine, Philadelphia, PA, United StatesDepartment of Cardiovascular Sciences/Center for Metabolic Disease Research, Temple University School of Medicine, Philadelphia, PA, United StatesDepartment of Cardiovascular Sciences/Center for Metabolic Disease Research, Temple University School of Medicine, Philadelphia, PA, United StatesDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United StatesDepartment of Cardiovascular Sciences/Center for Metabolic Disease Research, Temple University School of Medicine, Philadelphia, PA, United StatesObesity, altered glucose homeostasis, hyperinsulinism, and reproductive dysfunction develops in female humans and mammals with hyperandrogenism. We previously reported that low dose dihydrotestosterone (DHT) administration results in metabolic and reproductive dysfunction in the absence of obesity in female mice, and conditional knock-out of the androgen receptor (Ar) in the liver (LivARKO) protects female mice from DHT-induced glucose intolerance and hyperinsulinemia. Since altered metabolic function will regulate reproduction, and liver plays a pivotal role in the reversible regulation of reproductive function, we sought to determine the reproductive phenotype of LivARKO mice under normal and hyperandrogenemic conditions. Using Cre/Lox technology, we deleted the Ar in the liver, and we observed LivARKO female mice have normal puberty timing, cyclicity and reproductive function. After DHT treatment, like control mice, LivARKO experience altered estrous cycling, reduced numbers of corpus lutea, and infertility. Liver Ar is not involved in hyperandrogenemia-induced reproductive dysfunction. The reproductive dysfunction in the DHT-treated LivARKO lean females with normal glucose homeostasis indicates that androgen-induced reproductive dysfunction is independent from metabolic dysfunction.https://www.frontiersin.org/articles/10.3389/fendo.2022.868572/fullPCOS: polycystic ovary syndromeDHTdihydrotestosteroneandrogen receptor (AR)liverpuberty
spellingShingle Mingxiao Feng
Sara Divall
Dustin Jones
Vaibhave Ubba
Xiaomin Fu
Xiaomin Fu
Ling Yang
Hong Wang
Xiaofeng Yang
Sheng Wu
Sheng Wu
Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor
Frontiers in Endocrinology
PCOS: polycystic ovary syndrome
DHT
dihydrotestosterone
androgen receptor (AR)
liver
puberty
title Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor
title_full Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor
title_fullStr Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor
title_full_unstemmed Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor
title_short Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor
title_sort comparison of reproductive function between normal and hyperandrogenemia conditions in female mice with deletion of hepatic androgen receptor
topic PCOS: polycystic ovary syndrome
DHT
dihydrotestosterone
androgen receptor (AR)
liver
puberty
url https://www.frontiersin.org/articles/10.3389/fendo.2022.868572/full
work_keys_str_mv AT mingxiaofeng comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT saradivall comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT dustinjones comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT vaibhaveubba comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT xiaominfu comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT xiaominfu comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT lingyang comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT hongwang comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT xiaofengyang comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT shengwu comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor
AT shengwu comparisonofreproductivefunctionbetweennormalandhyperandrogenemiaconditionsinfemalemicewithdeletionofhepaticandrogenreceptor